Publication | Closed Access

Immunomodulatory drugs inhibit expression of cyclooxygenase-2 from TNF-α, IL-1β, and LPS-stimulated human PBMC in a partially IL-10-dependent manner

InflammationCytokineAnti-inflammatoryLps-stimulated Human PbmcImmune Cell DevelopmentIl-10-dependent MannerMedicineImmune RegulationPharmacologyImmunologyPharmacotherapyImmune FunctionImmunosuppressionImmune SystemImmunotherapy